MedTrace Logo

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

NCT04645745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-01-14

No results posted yet for this study

Summary

The main aim of this study is to evaluate the effect of myo-inositol and alpha-lactalbumin treatment on HOMA-index improvement in two different groups of women, belonging to the Mexican and Italian population, both affected by Polycystic Ovary Syndrome.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DIETARY_SUPPLEMENT

myo-inositol, alpha-lactalbumin, folic acid

Evaluating the improvement vs the baseline after three and six months of treatment

Sponsors & Collaborators

  • Hospital Juarez de Mexico

    collaborator OTHER_GOV

  • AGUNCO Obstetrics and Gynecology Centre

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-15
Primary Completion
2020-01-31
Completion
2020-02-28

Countries

  • Italy
  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645745 on ClinicalTrials.gov